Classement en actions
#6891
BELLUS Health Inc. is a biopharmaceutical firm in the clinical development... BELLUS Health Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to creating new therapeutic options for intractable chronic cough (RCC) and various other conditions characterized by heightened cough sensitivity. The company's primary investigational compound, BLU-5937, functions as a P2X3 receptor antagonist. This drug is currently progressing through Phase II clinical trials, where it is being assessed for its potential in treating both RCC and persistent itching. Founded in 1993, BELLUS Health Inc. is headquartered in Laval, Canada.
Prix de l'action
$14.30
Dernière synchronisation: 2023-06-29
Capitalisation boursière
$1.81B
Changement (1 jour)
-2.81%
Échange BELLUS Health Inc. (BLU)
Le prix BLU avec la capitalisation boursière de B
Capitalisation boursière de BELLUS Health Inc.(BLU)
Capitalisation boursière: $1.81B
En August 2026, BELLUS Health Inc. a une capitalisation boursière de $1.81B. Cela fait de BELLUS Health Inc. la 6891st entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de BELLUS Health Inc. du 2000 au 2026
BLU par rapport au top 5 des plus populaires stocks
| Prix pour BLU |
|
L’actif B |
La capitalisation boursière de B |
Résultats |
|
|
|
|
$5.532T
|
+304,999.94%
|
|
|
|
|
$4.608T
|
+254,067.10%
|
|
|
|
|
$4.096T
|
+225,797.86%
|
|
|
|
|
$3.748T
|
+206,647.35%
|
|
|
|
|
$2.761T
|
+152,204.78%
|
